Antares Pharma, Inc. (ATRS)

[jab91252]

Not the post really, but the post leading to the site:

http://www.evaluategroup.com/Universal/View.aspx?type=Report&id={23D6C352-1933-41D7-A788-054D46E19AAA}¶ms=%3CPARAMS%20currencyId=%220%22%3E%3CPARAM%20linkKind=%221%22%20compId=%221019%22%20name=%22allergy%22%20itemId=%225b%22%20/%3E%3C/PARAMS%3E

We know the settlement date is June 2015 - any other detail(s) of the settlement is confidential. I don't trust the information contained on the site above that notes Antares as the company when it should be TEVA and then notes a world wide launch of 9/30/2014. I've seen nothing from TEVA pr about a pending worldwide launch of the generic epipen. If TEVA is not barred from launching world wide as per the settlement date of June 2015, then why aren't they already marketing worldwide? They certainly have the pens in stock.

Getting into the worldwide market (ex US & Canada) would be nice (while not producing very good margins) so I don't assign any meaningful financial benefit to WW. The big bucks is connected with June 2015 and the US/Canada market.